IP Library Assignment 042877/0351
Patent Assignment
Reel/Frame 042877/0351

Release of Security Interest

Recorded: 2017-06-30 Pages: 6
Assignor
BANK OF AMERICA, N.A.
Executed: 2017-06-29
Assignees
PHIBRO ANIMAL HEALTH CORPORATION
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NEW JERSEY, 07666
PRINCE AGRI PRODUCTS, INC.
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NEW JERSEY, 07666
OMNIGEN RESEARCH, LLC
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NEW JERSEY, 07666
Covered Properties (16)
Microbiological Process for Making Uk-61,689
Patent: 5,602,012 →
Application: 08/344,313 →
Preparation of Near-Neutral Anionic Salt Feed Minerals
Patent: 5,556,634 →
Application: 08/421,199 →
Actinomadura Roseorufa for Making Uk-61,689
Patent: 5,679,563 →
Application: 08/468,171 →
Anticoccidial Composition of Uk-61,689 and Actinomadura Mycelium
Patent: 5,693,524 →
Application: 08/470,306 →
Palatable Anionic Feed Mineral Concentrate
Patent: 6,120,815 →
Application: 09/429,706 →
Augmentation of Titer for Vaccination in Animals
Patent: 8,142,798 →
Application: 11/380,359 →
Publication: US 2007/0253983
Methods and Compositions for the Inhibition of Growth of Infectious Aspergillus Fumigatus and Other Mycotic Organisms in the Gut of Mammalian and Avian Species
Patent: 7,939,066 →
Application: 11/457,176 →
Publication: US 2006/0239992
Use of Beta-1,3 (4)-Endoglucanohydrolase, Beta-1,3 (4) Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function
Patent: 8,236,303 →
Application: 11/668,375 →
Publication: US 2007/0202092
Use of pre-dissolved pristinamycin-type and polyether ionophore type antimicrobial agents in the production of ethanol
Application: 11/806,591 →
Publication: US 2008/0003215
Viral-based antimicrobial agent use in ethanol production
Application: 12/801,180 →
Publication: US 2010/0330041
Use of predissolved pristinamycin-type and polyether ionophore type antimicrobial agents in the production of ethanol
Patent: 9,386,770 →
Application: 13/067,385 →
Publication: US 2011/0294725
Augmentation of Titer for Vaccination in Animals
Patent: 8,431,133 →
Application: 13/400,520 →
Publication: US 2012/0156248
Use of Beta-1,3 (4)-Endoglucanohydrolase, Beta-1,3 (4)-Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function
Patent: 8,568,715 →
Application: 13/566,433 →
Publication: US 2013/0017211
Augmentation of Titer for Vaccination in Animals
Patent: 8,663,644 →
Application: 13/872,935 →
Publication: US 2013/0236482
Medicated Particulate Animal Feed Supplements and Methods of Preparation
Patent: 9,497,981 →
Application: 13/920,542 →
Publication: US 2014/0004195
Use of Beta-1,3 (4)-Endoglucanohydrolase, Beta-1,3 (4)-Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function
Patent: 8,834,868 →
Application: 14/035,812 →
Publication: US 2014/0023633
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 3, 2009
From: PUNTENNEY, STEVEN B.; FORSBERG, NEIL E.
To: OMNIGEN RESEARCH, LLC
Reel/Frame 023599/0263 →
Assignment of Assignor's Interest Aug 3, 2012
From: PUNTENNEY, STEVEN B.; FORSBERG, NEIL E.
To: OMNIGEN RESEARCH, LLC
Reel/Frame 028722/0275 →
Assignment of Assignor's Interest Sep 11, 2013
From: FORSBERG, NEIL ELLIOTT; PUNTENNEY, STEVEN BRUCE
To: OMNIGEN RESEARCH, LLC
Reel/Frame 031186/0691 →
Assignment of Assignor's Interest Sep 11, 2013
From: FORSBERG, NEIL ELLIOTT; PUNTENNEY, STEVEN BRUCE
To: OMNIGEN RESEARCH, LLC
Reel/Frame 031186/0094 →
Assignment of Assignor's Interest Oct 28, 2013
From: PUNTENNEY, STEVEN B.; FORSBERG, NEIL E.
To: OMNIGEN RESEARCH, LLC
Reel/Frame 031487/0542 →
Release of Security Interest in Patents Recorded at Reel 029910 Frame 0602 Apr 17, 2014
From: BANK OF AMERICA, N.A.
To: OMNIGEN RESEARCH, LLC
Reel/Frame 032712/0690 →
Release of Security Interest in Patents Recorded at Reel 024933 Frame 0541 Apr 17, 2014
From: BANK OF AMERICA, NA, AS ADMINISTRATIVE AGENT
To: PHIBRO ANIMAL HEALTH CORPORATION; PHIBRO-TECH, INC.
Reel/Frame 032712/0695 →
Patent Security Agreement Apr 17, 2014
From: PHIBRO ANIMAL HEALTH CORPORATION; PRINCE AGRI PRODUCTS, INC.; OMNIGEN RESEARCH, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 032712/0701 →
Security Interest Jun 30, 2017
From: PHIBRO ANIMAL HEALTH CORPORATION; OMNIGEN RESEARCH, LLC; PRINCE AGRI PRODUCTS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042877/0441 →
Security Interest Jul 15, 2024
From: PHIBRO ANIMAL HEALTH CORPORATION; PRINCE AGRI PRODUCTS, INC.; OMNIGEN RESEARCH, LLC
To: COÖPERATIEVE RABOBANK U.A., NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 068370/0043 →
Release of Security Interest in Patents at Reel 42877, Frame 0441 Jul 17, 2024
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: PHIBRO ANIMAL HEALTH CORPORATION; OMNIGEN RESEARCH, LLC; PRINCE AGRI PRODUCTS, INC.
Reel/Frame 068404/0550 →